Genotype, phenotype and outcomes in colorectal cancer
Stage II/III CRCs are currently treated by surgery, then stage III and stage II patients exhibiting high-risk pathological features undergo a course of 5-FUbased adjuvant chemotherapy, often with oxaliplatin added. Improved characterisation of stage 11/111 tumours is required in order to improve the...
| Main Author: | |
|---|---|
| Published: |
University of Leeds
2016
|
| Subjects: | |
| Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.713695 |